Northrop Grumman (NOC) Q1 2026 earnings review
Aeronautics Drives Rebound While Easy Comps Flatter the Bottom Line
Northrop Grumman's Q1 2026 headlines look spectacular—Operating Income up 73% and EPS up 85%—but these figures are heavily inflated by the absence of last year's $477M B-21 loss provision. Beneath the easy comparisons, the core business delivered stable 5% organic sales growth. Aeronautics Systems was the standout performer, surging 17% on B-21 production expansion, while Mission Systems delivered excellent margin expansion. The only glaring weakness was Space Systems, which shrank 3% and suffered a margin hit due to a GEM 63XL launch anomaly. Full-year guidance was completely reaffirmed, signaling management's confidence in the current trajectory.
🐂 Bull Case
Aeronautics sales surged 17%, driven by the new B-21 capacity agreement with the U.S. Air Force and the E-130J TACAMO ramp. Operating margin stabilized at a healthy 9.3%.
Mission Systems delivered outstanding 15.1% operating margins (up 220 bps YoY), proving that prior-year investments in restricted business opportunities are now yielding substantial bottom-line leverage.
🐻 Bear Case
Space Systems is reversing. Sales dropped 3% due to the NGI program wind-down, and operating income fell 17% after a $71M unfavorable EAC adjustment tied to a GEM 63XL launch anomaly.
Free Cash Flow was deeply negative at -$1.82B. While management attributes this to historical seasonal working capital timing, a burn of this magnitude leaves zero room for execution errors in the second half of the year.
⚖️ Verdict: ⚪
Bullish leaning. The headline numbers exaggerate the operational reality, but 5% organic growth and a $95.6B backlog demonstrate a robust and reliable demand environment. The B-21 program moving from a margin drag into a formalized capacity expansion phase is a major long-term catalyst.
Key Themes
Aeronautics Systems Flipping from Liability to Leader
After a disastrous Q1 2025 that featured a $477M B-21 loss provision, Aeronautics Systems reversed its fortunes to become the company's primary growth engine. Sales accelerated 17% YoY to $3.28B. Crucially, this isn't just an easy comp—management secured agreements with the USAF to increase B-21 production capacity and accelerate the aircraft's production rate, translating into sustainable future volume.
Space Systems Hit by Launch Anomaly
Space Systems was the clear laggard, decelerating to a 3% sales decline ($2.48B). The wind-down of the Next Generation Interceptor (NGI) stripped $98M from the top line. More concerning is the bottom line: a $71M unfavorable EAC adjustment on the GEM 63XL program due to a Q1 launch anomaly crushed margins, dropping the segment's operating margin from 11.0% a year ago to 9.5%.
Mission Systems Margins Expanding
Mission Systems proved to be the profitability anchor. While sales grew a modest 2%, operating income jumped 20%. Margins expanded significantly to 15.1% (up from 12.9% in 25Q1). Management attributes this structural step-up to past investments in restricted business opportunities and favorable net EAC adjustments.
Sentinel and Defense Systems Stabilizing
Defense Systems organic sales grew a healthy 10% (adjusting for the $72M drag from the training services divestiture). Growth was broad-based, fueled by the Sentinel program ramp-up, tactical solid rocket motors, and the Integrated Battle Command System (IBCS). Operating margins slightly compressed from 9.9% to 9.7% due to lower EAC adjustments, but absolute operating income still grew 3%.
Severe Seasonal Cash Bleed
First quarter cash performance was abysmal, albeit historically consistent. Operating cash flow was -$1.65B, driven by surging unbilled receivables and trade working capital build-ups. While CapEx dropped 35% YoY to $167M, overall Free Cash Flow remained pinned at -$1.82B. Achieving the full-year target of $3.1-$3.5B requires a colossal, flawless second-half cash generation effort.
Other KPIs
Stable. The total backlog sits practically flat sequentially compared to $95.68B at the end of FY25. Q1 net awards of $9.8B equaled revenue recognition, maintaining a healthy ~1.0x book-to-bill ratio. $4.9B of the new awards were highly lucrative restricted programs.
Favorable. The tax rate dropped 180 basis points YoY from 16.8%, primarily due to higher research credits and a specific benefit related to recent IRS guidance on the Corporate Alternative Minimum Tax. This directly subsidized the EPS beat.
Deteriorating. Unallocated corporate expenses jumped 55% YoY (from $58M in 25Q1), driven by a near-doubling of 'Other unallocated corporate expense' to $69M. While small relative to the $989M operating income, this represents a notable margin leak.
Guidance
Stable. The company wholly reaffirmed its 2026 sales guidance. The midpoint ($43.75B) implies approximately 4.3% YoY growth compared to FY25 sales ($41.95B). Q1 2026's 4% growth rate shows they are tracking perfectly to this target.
Stable. Guidance is maintained. Achieving this will require sustained operational excellence to overcome the heavily back-weighted cash flow and earnings curve expected in H2 2026.
Stable. Maintained at prior levels. Given the -$1.82B burn in Q1, the company must generate roughly $5.1B in positive Free Cash Flow over the remaining three quarters to hit the midpoint. This highlights massive reliance on Q4 inventory liquidations and milestone payments.
Stable. Tracking well. Q1 delivered $1,072M, representing about 21.7% of the midpoint. With historical trends leaning heavier into the back half, achieving the $4.925B midpoint looks highly probable barring unforeseen program execution failures.
Key Questions
GEM 63XL Anomaly Fallout
Can management quantify the timeline and financial limits of the GEM 63XL anomaly? Does the $71M EAC hit fully capture the remediation costs, or is there a risk of further margin deterioration in Space Systems?
B-21 Acceleration Dynamics
The agreement to increase B-21 production capacity was secured. How much incremental CapEx will this require from Northrop Grumman, and at what timeline will this transition from a margin-dilutive investment phase into accretive production?
Sentinel Restructuring Milestones
With the agreement to accelerate Sentinel IOC, how does the restructured timeline impact the near-term margin profile of the Defense Systems segment, considering the shift in risk on the command and launch facilities?
Path to FCF Guidance
Given the $1.82B cash outflow in Q1, what specific working capital unlocks and milestone payment timings give management confidence in hitting the $3.3B midpoint for the year?